Tech transfer and licensing professionals as well as IP attorneys looking to assess the impact of two critical patents cases – and adjust their strategies based on expert recommendations – will benefit from two timely audioconferences coming next month.
On August 17th, a top level team of legal experts and TTO professionals will specifically address the implications of the Supreme Court’s Bilski decision on university IP and the future patentability of business methods. Bilski: The Impact of the Final Decision on University TTOs will address many key questions arising from the ruling, including: How will inventions of an “abstract” nature be defined? How will the “machine or transformation” test continue to influence PTO examiners? How should patent prosecution change to help ensure validity? How does the decision affect plans for appeals/reconsiderations? What about existing method patents, and the impact on both value and infringement? For complete details and to register, CLICK HERE.
The following Thursday, August 26th, delves into the complex issues surrounding gene-based patents in the wake of the Myriad decision. The Future of Patenting in Biomedicine: An In-Depth Look at the Effect of the Myriad Case on Gene Patenting and Genetic Diagnostics will address host of issues including:
- How to analyze diagnostic claims
- The significance of the “detecting” step with regard to novelty
- The relevance of any “mental steps” involved in patent claims
- What to expect from the Federal Circuit
- The significance of genetic methods as a subset of medical diagnostic claims
- The relationship between information per se and methods of obtaining information.
For complete information and to enroll, please CLICK HERE.
Plus, don’t miss these upcoming distance learning programs:
Posted July 27th, 2010 under Audioconferences, Intellectual Property Marketing
|
|
|
|
Write a comment